These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 7682261)
41. Noninvasive visualization of coronary arterial aneurysm in infants and young children with mucocutaneous lymph node syndrome with two dimensional echocardiography. Hiraishi S; Yashiro K; Kusano S Am J Cardiol; 1979 Jun; 43(6):1225-33. PubMed ID: 443180 [TBL] [Abstract][Full Text] [Related]
42. Collateral vessels assessed by myocardial contrast echocardiography in patients with coronary artery lesions after Kawasaki disease. Kinoshita Y; Suzuki A; Nakajima T; Ono Y; Arakaki Y; Kamiya T Heart Vessels; 1996; 11(4):203-10. PubMed ID: 9119810 [TBL] [Abstract][Full Text] [Related]
43. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953 [TBL] [Abstract][Full Text] [Related]
44. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications. Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293 [TBL] [Abstract][Full Text] [Related]
45. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease. Cameron SA; Carr M; Pahl E; DeMarais N; Shulman ST; Rowley AH Arch Dis Child; 2019 May; 104(5):451-455. PubMed ID: 30413485 [TBL] [Abstract][Full Text] [Related]
46. Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Shulman ST; McAuley JB; Pachman LM; Miller ML; Ruschhaupt DG Am J Dis Child; 1987 Apr; 141(4):420-5. PubMed ID: 3565328 [TBL] [Abstract][Full Text] [Related]
47. High persistence rate of established coronary artery lesions secondary to Kawasaki disease among a panethnic Canadian population. Turner-Gomes S; Rose V; Brezina A; Smallhorn J; Rowe RD J Pediatr; 1986 Jun; 108(6):928-32. PubMed ID: 3712158 [TBL] [Abstract][Full Text] [Related]
48. Cardiac and coronary arterial involvement in infants and children from New England with mucocutaneous lymph node syndrome (Kawasaki disease). Angiocardiographic-echocardiographic correlations. Chung KJ; Brandt L; Fulton DR; Kreidberg MB Am J Cardiol; 1982 Jul; 50(1):136-42. PubMed ID: 7090996 [TBL] [Abstract][Full Text] [Related]
50. Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. Noto N; Ayusawa M; Karasawa K; Yamaguchi H; Sumitomo N; Okada T; Harada K J Am Coll Cardiol; 1996 Apr; 27(5):1251-6. PubMed ID: 8609352 [TBL] [Abstract][Full Text] [Related]
51. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience. Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145 [TBL] [Abstract][Full Text] [Related]
52. Detection of coronary arterial lesions by two dimensional echocardiography in patients with Kawasaki disease. Ishihara H; Watanabe S; Izumida N; Tuchiya S; Hosaki J Bull Tokyo Med Dent Univ; 1984 Sep; 31(3):139-43. PubMed ID: 6598414 [TBL] [Abstract][Full Text] [Related]
53. Criterion for early prediction of coronary artery involvement by clinical manifestations in patients with Kawasaki disease. Ishihara H; Izumida N; Hosaki J Bull Tokyo Med Dent Univ; 1985 Jun; 32(2):77-89. PubMed ID: 3864563 [TBL] [Abstract][Full Text] [Related]
55. [Visualization of peripheral left coronary aneurysms in Kawasaki disease by subcostal two-dimensional echocardiography]. Maeda T; Yoshida H; Funabashi T; Nakaya S; Takabatake S; Ohno T; Taniguchi N J Cardiogr; 1983 Dec; 13(4):881-91. PubMed ID: 6678955 [TBL] [Abstract][Full Text] [Related]
56. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. Tse SM; Silverman ED; McCrindle BW; Yeung RS J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960 [TBL] [Abstract][Full Text] [Related]
57. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997 [TBL] [Abstract][Full Text] [Related]
58. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. Barron KS; Murphy DJ; Silverman ED; Ruttenberg HD; Wright GB; Franklin W; Goldberg SJ; Higashino SM; Cox DG; Lee M J Pediatr; 1990 Oct; 117(4):638-44. PubMed ID: 2213395 [TBL] [Abstract][Full Text] [Related]
59. Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study. Berdej-Szczot E; Firek-Pędras M; Szydłowski L; Krzystolik-Ładzińska J; Klimek K; Małecka-Tendera E Kardiol Pol; 2013; 71(12):1279-86. PubMed ID: 23990228 [TBL] [Abstract][Full Text] [Related]
60. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]